Specialty pharma company Assertio Holdings has expanded its portfolio through a deal with Aquestive Therapeutics, paying $9 million upfront for exclusive rights to the Sympazan oral film formulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback